|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
573,600,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$179.79 - $179.79 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Butitta Cynthia M |
Chief Operating Officer |
• – – |
2017-02-27 |
4 |
AS |
$53.15 |
$544,178 |
D/D |
(10,000) |
117,795 |
|
- |
|
| Butitta Cynthia M |
Chief Operating Officer |
• – – |
2017-02-27 |
4 |
OE |
$1.35 |
$13,500 |
D/D |
10,000 |
127,795 |
|
- |
|
| Wiezorek Jeffrey |
SVP Clinical Development |
• – – |
2017-02-01 |
4 |
AS |
$51.21 |
$76,820 |
D/D |
(1,500) |
20,695 |
|
- |
|
| Wiezorek Jeffrey |
SVP Clinical Development |
• – – |
2017-02-01 |
4 |
OE |
$6.89 |
$10,335 |
D/D |
1,500 |
22,195 |
|
- |
|
| Butitta Cynthia M |
Chief Operating Officer |
• – – |
2017-01-31 |
4 |
AS |
$50.56 |
$505,562 |
D/D |
(10,000) |
117,795 |
|
- |
|
| Butitta Cynthia M |
Chief Operating Officer |
• – – |
2017-01-31 |
4 |
OE |
$1.35 |
$13,500 |
D/D |
10,000 |
127,795 |
|
- |
|
| Butitta Cynthia M |
Chief Operating Officer |
• – – |
2017-01-06 |
4 |
AS |
$50.13 |
$501,289 |
D/D |
(10,000) |
117,795 |
|
- |
|
| Butitta Cynthia M |
Chief Operating Officer |
• – – |
2017-01-06 |
4 |
OE |
$1.35 |
$13,500 |
D/D |
10,000 |
127,795 |
|
- |
|
| Wiezorek Jeffrey |
SVP Clinical Development |
• – – |
2017-01-06 |
4 |
AS |
$50.00 |
$75,000 |
D/D |
(1,500) |
20,695 |
|
- |
|
| Wiezorek Jeffrey |
SVP Clinical Development |
• – – |
2017-01-06 |
4 |
OE |
$6.89 |
$10,335 |
D/D |
1,500 |
22,195 |
|
- |
|
| Clark Ian T |
Director |
– • – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
4,690 |
4,690 |
|
- |
|
| Belldegrun Arie |
Chairman, President and CEO |
• • – |
2016-12-27 |
4 |
A |
$0.00 |
$0 |
D/D |
43,800 |
68,507 |
|
- |
|
| Wiezorek Jeffrey |
SVP Clinical Development |
• – – |
2016-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
5,600 |
20,695 |
|
- |
|
| Tomasello Shawn |
Chief Commercial Officer |
• – – |
2016-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,600 |
60,235 |
|
- |
|
| Moore Timothy L. |
EVP, Technical Operations |
• – – |
2016-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
8,400 |
58,400 |
|
- |
|
| Jenkinson Paul L |
Chief Financial Officer |
• – – |
2016-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
6,600 |
6,600 |
|
- |
|
| Chang David D |
EVP, R&D, Chief Medical Off. |
• – – |
2016-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
24,800 |
49,923 |
|
- |
|
| Kim Helen Susan |
EVP, Business Development |
• – – |
2016-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
10,600 |
18,664 |
|
- |
|
| Butitta Cynthia M |
Chief Operating Officer |
• – – |
2016-12-22 |
4 |
A |
$0.00 |
$0 |
D/D |
24,800 |
117,795 |
|
- |
|
| Tomasello Shawn |
Chief Commercial Officer |
• – – |
2016-12-20 |
4 |
S |
$50.86 |
$249,265 |
D/D |
(4,901) |
49,635 |
|
- |
|
| Kim Helen Susan |
EVP, Business Development |
• – – |
2016-12-20 |
4 |
S |
$50.86 |
$47,605 |
D/D |
(936) |
8,064 |
|
- |
|
| Chang David D |
EVP, R&D, Chief Medical Off. |
• – – |
2016-12-20 |
4 |
S |
$50.86 |
$90,938 |
D/D |
(1,788) |
25,123 |
|
- |
|
| Wiezorek Jeffrey |
SVP Clinical Development |
• – – |
2016-12-20 |
4 |
S |
$50.86 |
$36,416 |
D/D |
(716) |
15,095 |
|
- |
|
| Belldegrun Arie |
Chairman, President and CEO |
• • – |
2016-12-20 |
4 |
S |
$50.86 |
$177,654 |
D/D |
(3,493) |
24,707 |
|
- |
|
| Butitta Cynthia M |
Chief Operating Officer |
• – – |
2016-12-20 |
4 |
S |
$50.86 |
$126,235 |
D/D |
(2,482) |
92,995 |
|
- |
|
387 Records found
|
|
Page 7 of 16 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
